Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trial Completed
624 Longitudinal scRNAseq profiling of PBMCs from melanoma patients treated with anti-CTLA4 or anti-PD1/CTLA4 combination elucidates mechanisms of immunotherapy resistance
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 624 Longitudinal scRNAseq profiling of PBMCs from melanoma patients treated with anti-CTLA4 or anti-PD1/CTLA4 combination elucidates mechanisms of immunotherapy resistance